Allworth Financial’s iTeos Therapeutics ITOS Stock Holding History

Allworth Financial’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40	Closed	-$399	–	4976
2025 Q2	$399	Buy	+40	New	+$322	﹤0.01%	4191
2024 Q4	–	Sell	-227	Closed	-$2.32K	–	4003
2024 Q3	$2.32K	Hold	227	–	–	﹤0.01%	2904
2024 Q2	$3.57K	Hold	227	–	–	﹤0.01%	2667
2024 Q1	$3.1K	Hold	227	–	–	﹤0.01%	2617
2023 Q4	$2.49K	Buy	227 +201	+773%	+$1.99K	﹤0.01%	2581
2023 Q3	$285	Buy	26 +5	+24%	+$64	﹤0.01%	3182
2023 Q2	$279	Sell	21 -33	-61%	-$471	﹤0.01%	3033
2023 Q1	$735	Buy	+54	New	+$967	﹤0.01%	2765
2022 Q4	–	Sell	-32	Closed	-$1K	–	3101
2022 Q3	$1K	Buy	+32	New	+$737	﹤0.01%	2413

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial's ITOS Position: Q3 2025 in Review

Allworth Financial sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 40 shares — an estimated $399 sold.

Allworth Financial first reported a position in ITOS in Q3 2022 and held it in 9 quarters. The position peaked at $3.57K in Q2 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Allworth Financial reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Allworth Financial sold 40 iTeos Therapeutics shares in Q3 2025, an estimated $399.
Allworth Financial first reported a position in iTeos Therapeutics in Q3 2022 and held it in 9 quarters.
Allworth Financial's iTeos Therapeutics position peaked at $3.57K in Q2 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.